J.P. Morgan Healthcare Conference (Emergent Biosolutions) - Jan 10, 2012 - Pfizer completed enrollment for SBI-087 P2 dose finding study in RA & completed dosing for P1 safety & PK study in SLE; Anticipated data from P2 dose regimen finding study in RA by Pfizer in H1 '12
Anticipated P2 trial data • Enrollment completion
|
|
SBI-087
-- -- --
Clinical development
2011 Accomplishments
- Completed enrollment for SBI-087 P2 dose finding study in RA (by Pfizer)
- Completed dosing for P1 safety and PK study in SLE (by Pfizer)
2012 Milestones
- Anticipated data from P2 dose regimen finding study in RA by Pfizer in H1 '12
|